Country for PR: United Kingdom
Contributor: PR Newswire Europe
Thursday, January 20 2022 - 23:02
AsiaNet
Victor Papamoniodis Joins Medison Pharma as VP International Markets
ZUG, Switzerland, Jan 20, 2022 /PRNewswire-AsiaNet/ --

Medison [https://www.medisonpharma.com], a global pharma company focused on 
providing access to highly innovative therapies to patients in international 
markets (“Medison”), is proud to announce the joining of Victor Papamoniodis in 
the newly created position of VP International Markets. Victor will be based in 
Zug, Switzerland, Medison’s international headquarters.

Victor will head Medison's markets outside of Israel and will focus on scaling 
up the company's presence across markets, while growing and nurturing 
relationships with Medison’s global partners.
 
Prior to joining Medison, Victor held the position of VP International & 
Emerging Markets at  Apellis Pharmaceuticals, Inc. Prior to that, he spent 9 
years at Vertex Pharmaceuticals Incorporated as GM for Distributors & Expansion 
Markets, responsible for multiple regions, including CEE, LATAM, Russia & MENA.
“I am delighted to join Medison’s global leadership at an exciting time of 
rapid growth and expansion into new markets. Medison creates a real paradigm 
shift in the pharma industry, positioning itself as the next-gen partner for 
biotech companies who wish to access international markets and serve patients 
in need,” said Victor Papamoniodis.

“Medison is set out to change patients’ lives in international markets, 
bridging the unbearable access gap and making the most innovative therapies 
accessible to patients,” said Meir Jakobsohn, Founder and CEO of Medison. “The 
experience and capabilities that Victor brings will take our international 
platform to the next level.”

“Adding Victor’s capabilities will accelerate Medison’s expansion into 
additional markets and regions, building a true unified platform for the 
benefit of partners and patients, globally,” added Gil Gurfinkel, VP Corporate 
Development of Medison.

About Medison Pharma

Medison is a global pharma company focused on providing access to highly 
innovative therapies to patients in international markets. Medison is the first 
to create an international commercialization platform for highly innovative 
therapies, helping to save and improve lives by making the best available novel 
treatments accessible to patients in international markets. Medison has a track 
record of multi-territorial partnerships with leading pharmaceutical and 
biotech companies seeking to expand their global reach. To learn more visit 
www.medisonpharma.com. 

Photo - https://mma.prnewswire.com/media/1729991/Medison_Pharma_VP.jpg
Logo - https://mma.prnewswire.com/media/1527224/MEDISON_Logo.jpg

Medison Contact
Maya Nix
Corporate Communications Lead
mayan@medison.co.il
+972-3-925-0260

Source: Medison Pharma

Translations

Japanese